Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders - PubMed (original) (raw)

Review

Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders

Lauren P McLaughlin et al. Curr Allergy Asthma Rep. 2017 Jan.

Abstract

Primary immunodeficiency disorders (PID) are a group of inborn errors of immunity with a broad range of clinical severity but often associated with recurrent and serious infections. While hematopoietic stem cell transplantation (HSCT) can be curative for some forms of PID, chronic and/or refractory viral infections remain a cause of morbidity and mortality both before and after HSCT. Although antiviral pharmacologic agents exist for many viral pathogens, these are associated with significant costs and toxicities and may not be effective for increasingly drug-resistant pathogens. Thus, the emergence of adoptive immunotherapy with virus-specific T lymphocytes (VSTs) is an attractive option for addressing the underlying impaired T cell immunity in many PID patients. VSTs have been utilized for PID patients following HSCT in many prior phase I trials, and may potentially be beneficial before HSCT in patients with chronic viral infections. We review the various methods of generating VSTs, clinical experience using VSTs for PID patients, and current limitations as well as potential ways to broaden the clinical applicability of adoptive immunotherapy for PID patients.

Keywords: Adoptive immunotherapy; Antiviral therapy; Cytotoxic T lymphocytes; Hematopoietic stem cell transplantation; Primary immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Drs. McLaughlin, Bollard, and Keller declare no conflicts of interest relevant to this manuscript.

Similar articles

Cited by

References

    1. Bousfiha AA, Jeddane L, Ailal F, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87. - PMC - PubMed
    1. Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015. - PubMed
    1. Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res. 2011;49(1–3):25–43. - PMC - PubMed
    1. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454–70. - PMC - PubMed
    1. Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126(3):602–610 e601–611. - PubMed

Publication types

MeSH terms

LinkOut - more resources